Orthocell Ltd has released a press release.
CelGro Pre-Submission Meeting Completed with the FDA
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Orthocell
- Orthocell Receives New Patent for Celgro Platform Technology
- OCC Reports First Product Use and Sales of Celgro in Italy
- Orthocell Appoints Exclusive Distributor in the UK
- New CelGro Arthroscopic Tendon Regeneration Study Commences
- Orthocell Announces Successful Ortho-ATI Study Results
Later from Orthocell
- OCC Reports First Product Use and Sales of CelGro in Ireland
- Preliminary Final Report and Annual Financial Statements
- CelGro used in Nano Medicine Breakthrough
- CelGro Used as Artificial Periosteum Repairs Bone
- Orthocell Receives A$2.5m R&D tax Incentive Refund
Follow Orthocell into a list and get an email when it puts out news.
Follow Orthocell